Slight gains made in global childhood vaccination rates, says new report

Woman gazing at baby

Frank Dejongh / UNICEF

Despite vaccine hesitancy spreading worldwide, the number of children receiving the diphtheria, tetanus, and pertussis (DTP) vaccine has slightly increased, according to the World Health Organization (WHO)-United Nation Children’s Fund (UNICEF) Estimates of National Immunization Coverage published today. 

DTP immunization rates often show how successful a country is at providing routine childhood vaccines. Almost 116 million infants (90%) globally received one dose of DTP, and 110 million babies (85%) were fully vaccinated with three shots. 

“Both figures rose a full percentage point from the 2024 levels,” Ephrem T. Lemango, MD, associate director for Health and Global Chief of Immunization at UNICEF, said during a press conference. 

“It is still not enough. Both DTP numbers, the first and the third dose, are 1% point below where we stood in 2019, and global coverage has been hovering generally within this same narrow range since 2009.”

Measles vaccination still too low

Baby receiving vaccine
Khadidja Markemal / UNICEF

While the report notes an increase in the number of children receiving DTP, 7.3 million of those babies never received their first dose of the measles vaccine. This drop-out makes it difficult to boost the measles vaccination to 95%—what’s needed to stop outbreaks. Worldwide, only 84% of children received one dose of the measles vaccine and 77% received the second. The lagging measles vaccination rates contributed to 57 countries experiencing measles outbreaks last year, including the United States, which is experiencing decades-high numbers.

“For measles, one of the worst and most contagious viruses, the challenge is no longer vaccine introduction. Every country uses the measles vaccine,” Kate O’Brien, MD, MPH, director of the Department of Immunization, Vaccines, and Biologicals at the WHO, said in the press conference. “The problem here is the failure to get these doses to all children.”

Both DTP numbers, the first and the third dose, are 1% point below where we stood in 2019, and global coverage has been hovering generally within this same narrow range since 2009.

Ephrem T. Lemango, MD

The experts expressed concern about the stubborn rate of “zero-dose” children. While there were about 750,000 fewer of these children last year than the year before, the number remains high.    

“The number of zero-dose children, which is those missing on all vaccines, decreased from about 14.2 million in 2024 to 13.5 million in 2025,” Lemango said. “The pace of reduction is too slow to reach the goals by the end of the decade.” 

Half of children who haven’t been immunized live in countries experiencing war and conflict. Yet there has also been an increase in the number of children missing immunizations in middle-and higher-income countries. 

“Coverage is slipping,” Lemango said. “These reasons could be structural and governance issues, shifting political will, and rising hesitance and misinformation that all of us need to deal with.” 

More widespread HPV vaccination needed

In 2025, the human papillomavirus (HPV) vaccine was offered in 162 countries, including 15 nations that introduced the vaccine that year. About 22.5 million girls (33%) received the first dose through regular medical care, an increase from 31% in 2024. 

“While still far from that 90% target by 2023, this now represents a substantial increase from only about 17% coverage in 2019,” O’Brien said. 

Girl being vaccinated
Mahmoud ALfilastini / UNICEF

Countries where Gavi, the Vaccine Alliance works have seen success in their HPV vaccination rates. 

“More than 95 million girls are vaccinated against HPV in Gavi-supported countries over the past five years,” Lemango  said. “This surpasses the alliance’s goal of reaching 86 million girls by the end of 2025. In other words, immunization programs in the least wealthy countries of the world are often closing vaccination gaps faster than the wealthier ones.” 

This week's top reads

Our underwriters

Unrestricted financial support provided by